Brukinsa launch date?

When was Brukinsa (zanubrutinib) first launched?

Brukinsa (zanubrutinib) was launched in the United States on November 14, 2019.[1]

What was Brukinsa’s original FDA approval date?

The FDA first approved Brukinsa for mantle cell lymphoma (MCL) on November 14, 2019—the same day it was launched.[1]

Are there other “launch” dates users might mean (EU/other countries)?

The term “launch date” can vary by country and by indication. If you meant a specific market (for example, Europe) or a later approved indication, the launch date can differ. DrugPatentWatch.com tracks U.S. patent/exclusivity information, which can help contextualize timing by region.[2]

Sources:
[1] https://www.drugs.com/history/brukinsa.html
[2] https://www.drugpatentwatch.com/